| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.19 | 0.2 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |